139 related articles for article (PubMed ID: 27564105)
1. The prognostic value of D-dimer levels in metastatic osteosarcoma patients treated with second-line chemotherapy.
Huang Y; Liu B; Sun Y; Zhang J; Yao Y; He A
Oncotarget; 2016 Oct; 7(40):65568-65576. PubMed ID: 27564105
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
Raj SD; Zhou X; Bueso-Ramos CE; Ravi V; Patel S; Benjamin RS; Vadhan-Raj S
Am J Clin Oncol; 2012 Oct; 35(5):462-7. PubMed ID: 21654313
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of D-dimer levels in endometrial cancer patients treated with intensity-modulated radiation therapy.
Yang X; Ren H; Sun Y; Zhang L; Yang X; Li H; Shao Y; Fu J
Oncotarget; 2017 Apr; 8(15):25279-25288. PubMed ID: 28445972
[TBL] [Abstract][Full Text] [Related]
4. The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma.
Huang Y; Shen Z; Yao Y; He A; Min D
Onco Targets Ther; 2021; 14():213-220. PubMed ID: 33469302
[TBL] [Abstract][Full Text] [Related]
5. D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy.
Go SI; Lee MJ; Lee WS; Choi HJ; Lee US; Kim RB; Kang MH; Kim HG; Lee GW; Kang JH; Lee JH; Kim SJ
Medicine (Baltimore); 2015 Jul; 94(30):e951. PubMed ID: 26222870
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a Nomogram-Based Model for Predicting the Prognostic Value of Inflammatory Biomarkers and Preoperative D-Dimer Level in Spinal Ewing's Sarcoma Family Tumors: A Retrospective Study of 83 Patients.
Xu K; Lou Y; Sun R; Liu Y; Li B; Li J; Huang Q; Wan W; Xiao J
World Neurosurg; 2019 Jan; 121():e104-e112. PubMed ID: 30218803
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Zhu LR; Li J; Chen P; Jiang Q; Tang XP
Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726
[TBL] [Abstract][Full Text] [Related]
8. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy.
Ge LP; Li J; Bao QL; Chen P; Jiang Q; Zhu LR
Clin Transl Oncol; 2015 Jan; 17(1):57-64. PubMed ID: 24997087
[TBL] [Abstract][Full Text] [Related]
11. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
13. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of plasma D-dimer levels in patients with small-cell lung cancer.
Chen Y; Yu H; Wu C; Li J; Jiao S; Hu Y; Tao H; Wu B; Li A
Biomed Pharmacother; 2016 Jul; 81():210-217. PubMed ID: 27261596
[TBL] [Abstract][Full Text] [Related]
15. Combination of D-dimer and carcinoembryonic antigen levels as a predictive and prognostic biomarker in advanced colorectal cancer patients.
Li H; Zhao S; Jing Z; Li J; Shuanying Y; Zhang N
J Cell Biochem; 2019 May; 120(5):8086-8092. PubMed ID: 30592316
[TBL] [Abstract][Full Text] [Related]
16. Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma.
Moon SH; Shin KH; Suh JS; Yang WI; Noh JK; Hahn SB
Yonsei Med J; 2005 Feb; 46(1):119-24. PubMed ID: 15744814
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of D-dimer in lung cancer.
İnal T; Anar C; Polat G; Ünsal İ; Halilçolar H
Clin Respir J; 2015 Jul; 9(3):305-13. PubMed ID: 24720709
[TBL] [Abstract][Full Text] [Related]
20. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
